Pharmaceutical stocks today: Nifty Pharma gained 3.13 per cent at 13,006.85 points.
Share prices of pharmaceutical stocks such as Cipla Limited and Sun Pharmaceuticals rallied on Friday, April 9, due to the growing demand of medicines and related products amid the second wave of the COVID-19 pandemic in the country. Cipla gained around five per cent and Sun Pharmaceutical Industries gained around four per cent in the session today. Among sectoral indices, Nifty Pharma gained 3.13 per cent at 13,006.85 points.
On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far. Whereas, Sun Pharmaceuticals opened on the NSE at Rs 613, touching an intra day high of Rs 642 and an intra day low of Rs 609.50.
Zydus Cadila seeks DCGI nod for use of PegiHep in Covid-19 treatment
April 05, 2021
Phase-3 clinical trials showed promising results in treating Covid-19
In what could be termed a major breakthrough in the disease management of Covid-19, drug major Cadila Healthcare Limited (Zydus Cadila) has said that initial Phase-III clinical trials of Pegylated Interferon Alpha 2b, PegiHep, showed promising results in the treatment of the novel coronavirus.
The interim results indicate that PegIFN, when administered early on, could help patients recover faster, avoiding many of the complications seen in the advanced stages of the disease.
The company has sought the Drugs Controller General of India’s approval for the use of Pegylated Interferon alpha-2b in treating Covid-19 in India. Pegylated Interferon alpha-2b, or PegiHepTM, is an approved drug in India and is being re-purposed for the treatment of Covid-19.
Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Ankylosing Spondylitis Market Research Report by Drug (Cimzia, Cosentyx, Enbrel, Humira, and Remicade), by Type of Molecule (Biologics and Small Molecules), by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
February 24, 2021 08:34 ET | Source: ReportLinker ReportLinker Lyon, FRANCE
New York, Feb. 24, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker
niravFebruary 20, 2021
Coherent Market Insights report on the
global Urokinase Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2020 to 2027. The report provides the overall market value of the global Urokinase Market for the period of 2020 to 2027, with 2019 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Urokinase Market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Urokinase Market.
niravFebruary 19, 2021
Coherent Market Insights report on the
global Urokinase Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2020 to 2027. The report provides the overall market value of the global Urokinase Market for the period of 2020 to 2027, with 2019 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Urokinase Market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Urokinase Market.